Anaphore Lands $39,895,617 New Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    10931 North Torrey Pines Road La Jolla, CA 92037
  • Company Description
    Anaphore was created through the acquisition of Borean Pharma ApS, a Danish biotechnology company with both a product portfolio and technology platforms for creating improved protein therapeutics. The Danish firm spent six years establishing the technologies and therapeutic pipeline that provides the strong foundation for Anaphore. Anaphore offers technology collaborations in all therapeutic areas. Anaphore’s internal product development opportunities will initially focus on immune-based diseases.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy